Forum Discussion
Disappointing news.
I just read on face book that CDK inhibitor Ribociclib has been rejected for listing on the PBS. This is very very disappointing news when we have metastatic breast cancer and are always hoping that ...
Disappointing indeed. I guess it is all about money though many drugs do make it onto the PBS every year. I wouldn't want to be the person who knocks any of them back, so yes, you have to wonder who does the sums and decides we can afford to save one group of people but not another.